<GlossaryTerm id="CDR0000765003"><TermName>VIP regimen</TermName><TermPronunciation>(… REH-jih-men)</TermPronunciation><TermDefinition><DefinitionText>An abbreviation for a chemotherapy combination used to treat advanced testicular cancer. It is often used in patients who cannot receive bleomycin. It includes the drugs etoposide (VePesid), ifosfamide, and cisplatin (Platinol). Also called VIP.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000766701" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;VIP regimen&quot;" language="en" id="_3"/><MediaLink ref="CDR0000766702" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;régimen VIP&quot;" language="es" id="_4"/><SpanishTermName>régimen VIP</SpanishTermName><SpanishTermDefinition><DefinitionText>Nombre de una quimioterapia combinada que se usa para el tratamiento del cáncer de testículo en estadio avanzado. Suele usarse en pacientes que no pueden recibir bleomicina. Incluye los medicamentos etopósido, (VePesid), ifosfamida y cisplatino (Platinol). También se llama VIP.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2014-10-02</DateFirstPublished><RelatedInformation><RelatedDrugSummaryRef UseWith="en" href="CDR0000764894" url="/about-cancer/treatment/drugs/VIP">VIP</RelatedDrugSummaryRef></RelatedInformation></GlossaryTerm>
